The smoke is finally clearing on decades of stigma. On Thursday, the White House Office of Management and Budget signed off on a proposal for the reclassification of marijuana, puffing the way forward from a Schedule I drug to a Schedule III drug.
Attorney General Merrick Garland on Tuesday recommended loosening restrictions on marijuana, a historic shift in federal drug policy that could broaden access to the drug for medicinal use and boost cannabis industries in states where it is legal.
While 24 states have legalized recreational marijuana use, it remains a criminal activity under the federal Controlled Substances Act, and bankruptcy courts generally have been a rather hostile forum for debtors employed in the marijuana industry.
An increasing number of law schools around the country are offering cannabis law courses, but some professors think that even more are needed. “We’re still playing catch-up.”
Even before the end of Prohibition in 1933, public concern about narcotics addiction had been mounting. In the latter half of the 19th century, various opioids and cocaine were used in “patent medicines” and were widely available for sale, with drug laws and their enforcement deferred to the states.
New Jersey now has the equivalent of hall monitors in some workplaces. Except these hall monitors—known officially as workplace impairment recognition experts—are keeping an eye on the adults in the building. They are looking for signs the adults are high.
Feel like curling up next to the fireplace with a good read? ABA Journal Managing Editor Kevin Davis has curated a selection of our favorite feature stories that ran in the magazine and online in 2022.
Justice Cannabis Co. is one of the biggest of the little guys in the rough-and-tumble, fast-paced and legally treacherous world of marijuana growing and selling.
While Indigenous communities have long integrated plant-based psychedelics such as peyote and ayahuasca into their spiritual practices, interest in using both natural and synthetic hallucinogenic substances to alleviate depression and anxiety as well as anorexia, substance use disorder and other mental health conditions has increased in recent decades.
Andrew Chadeayne, who holds a doctorate in chemistry, is also a patent lawyer. His experience includes intellectual property work for pharmaceutical companies and a major freight forwarder. But it was his work for the revolutionary cannabis research company Ebbu that ignited his interest in developing and commercializing the mind-altering properties of much-maligned plants.
Under federal law, the decriminalized marijuana industry is in a slightly precarious position. Congress has prevented the Department of Justice from interfering with state-legal medical marijuana, but it left the DOJ free to enforce federal law against state-legal recreational marijuana businesses.
The ABA Journal wants to host and facilitate conversations among lawyers about their profession. We are now accepting thoughtful, non-promotional articles and commentary by unpaid contributors.
